Structural and functional characterization of the NHR2 and Runt domains of AML1/ETO.

被引：0
|
作者：
Cheney, MD
Liu, YZ
Zhou, YP
Chruszcz, M
Laue, TM
Minor, W
Bushweller, JH
Speck, NA
机构：
[1] Dartmouth Coll Sch Med, Dept Biochem, Hanover, NH USA
[2] Univ Virginia, Dept Mol Physiol & Biophys, Charlottesville, VA 22903 USA
[3] Univ New Hampshire, Dept Biochem, Durham, NH 03824 USA
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
482
引用
收藏
页码：141A / 141A
页数：1
相关论文
共 50 条
  • [31] Biochemical and in vivo characterization of amino acid substitutions in the Runx1 (AML1) runt domain found in FPD/AML, AML M0, and cleidocranial dysplasia (CCD) patients
    Matheny, CJ
    Corpora, T
    Speck, ME
    Gu, TL
    Bushweller, JH
    Speck, NA
    BLOOD, 2004, 104 (11) : 135A - 135A
  • [32] YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AML
    Ze Chen
    Yang-Liu Shao
    Li-Li Wang
    Ji Lin
    Ji-Bin Zhang
    Yi Ding
    Bin-bin Gao
    Dai-Hong Liu
    Xiao-Ning Gao
    Oncogene, 2021, 40 : 3786 - 3798
  • [33] YTHDF2 is a potential target of AML1/ETO-HIF1α loop-mediated cell proliferation in t(8;21) AML
    Chen, Ze
    Shao, Yang-Liu
    Wang, Li-Li
    Lin, Ji
    Zhang, Ji-Bin
    Ding, Yi
    Gao, Bin-bin
    Liu, Dai-Hong
    Gao, Xiao-Ning
    ONCOGENE, 2021, 40 (22) : 3786 - 3798
  • [34] The AML1/ETO target LAT2 membrane adaptor molecule is regulated during normal monocytic differentiation
    Duque-Afonso, Jesus
    Solari, Leticia
    Luebbert, Michael
    BLOOD, 2007, 110 (11) : 709A - 709A
  • [35] Functional mutagenesis of AML1/RUNX1 and PEBP2β/CBFβ define distinct, non-overlapping sites for DNA recognition and heterodimerization by the Runt domain
    Nagata, T
    Werner, MH
    JOURNAL OF MOLECULAR BIOLOGY, 2001, 308 (02) : 191 - 203
  • [36] Biallelic and heterozygous point mutations in the runt domain of the AML1/PEBP2αB gene associated with myeloblastic leukemias
    Osato, M
    Asou, N
    Abdalla, E
    Hoshino, K
    Yamasaki, H
    Okubo, T
    Suzushima, H
    Takatsuki, K
    Kanno, T
    Shigesada, K
    Ito, Y
    BLOOD, 1999, 93 (06) : 1817 - 1824
  • [37] Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFβ (vol 104, pg 755, 2001)
    Tahirov, TH
    Inoue-Bungo, T
    Morii, H
    Fujikawa, A
    Sasaki, M
    Kimura, K
    Shiina, M
    Sato, K
    Kumasaka, T
    Yamamoto, M
    Ishii, S
    Ogata, K
    CELL, 2001, 105 (02) : 291 - 291
  • [38] Functional characterization of TEL/AML1 fusion protein in the regulation of human CR1 gene promoter
    Song, H
    Kim, JH
    Rho, JK
    Park, SY
    Kim, CG
    Choe, SY
    MOLECULES AND CELLS, 1999, 9 (05) : 560 - 563
  • [39] The AML1/ETO(MTG8) and AML1/EVI-1 leukemia-associated chimeric oncoproteins accumulate PEBP2 beta(CBF beta) in the nucleus more efficiently than wild-type AML1.
    Tanaka, K
    Tanaka, T
    Kurokawa, M
    Imai, Y
    Ogawa, S
    Hiebert, SW
    Mitani, K
    Yazaki, Y
    Hirai, H
    BLOOD, 1996, 88 (10) : 2188 - 2188
  • [40] Biallelic and heterozygous point mutations in the Runt domain of the AML1/pebp2αb gene associated with myeloblastic leukemias.
    Asou, N
    Osato, M
    Abdalla, E
    Hoshino, K
    Yamasaki, H
    Okubo, T
    Suzushima, H
    Kawakita, M
    Takatsuki, K
    Kanno, T
    Shigesada, K
    Ito, Y
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 73 - 73
12345